Annual D&A
$2.56 M
+$499.00 K+24.21%
December 31, 2024
Summary
- As of March 12, 2025, XENE annual depreciation & amortization is $2.56 million, with the most recent change of +$499.00 thousand (+24.21%) on December 31, 2024.
- During the last 3 years, XENE annual D&A has risen by +$1.65 million (+182.56%).
- XENE annual D&A is now at all-time high.
Performance
XENE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$633.00 K
-$36.00 K-5.38%
December 31, 2024
Summary
- As of March 12, 2025, XENE quarterly depreciation & amortization is $633.00 thousand, with the most recent change of -$36.00 thousand (-5.38%) on December 31, 2024.
- Over the past year, XENE quarterly D&A has stayed the same.
- XENE quarterly D&A is now -63.49% below its all-time high of $1.73 million, reached on September 30, 2023.
Performance
XENE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.56 M
+$1.26 M+97.23%
December 31, 2024
Summary
- As of March 12, 2025, XENE TTM depreciation & amortization is $2.56 million, with the most recent change of +$1.26 million (+97.23%) on December 31, 2024.
- Over the past year, XENE TTM D&A has stayed the same.
- XENE TTM D&A is now -14.27% below its all-time high of $2.99 million, reached on September 30, 2023.
Performance
XENE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XENE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | 0.0% | 0.0% |
| 3 y3 years | +182.6% | +68.3% | +135.7% |
| 5 y5 years | +496.7% | +68.3% | +135.7% |
XENE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +182.6% | -63.5% | +200.6% | -14.3% | +182.6% |
| 5 y | 5-year | at high | +496.7% | -63.5% | +200.6% | -14.3% | +496.7% |
| alltime | all time | at high | +496.7% | -63.5% | +200.6% | -14.3% | +1362.9% |
Xenon Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.56 M(+24.2%) | $633.00 K(-5.4%) | $2.56 M(+97.2%) |
| Sep 2024 | - | $669.00 K(+1.5%) | $1.30 M(-45.1%) |
| Jun 2024 | - | $659.00 K(+10.0%) | $2.36 M(+2.5%) |
| Mar 2024 | - | $599.00 K(-195.2%) | $2.31 M(+11.9%) |
| Dec 2023 | $2.06 M(+46.7%) | -$629.00 K(-136.3%) | $2.06 M(-31.0%) |
| Sep 2023 | - | $1.73 M(+188.0%) | $2.99 M(+85.5%) |
| Jun 2023 | - | $602.00 K(+70.1%) | $1.61 M(+16.4%) |
| Mar 2023 | - | $354.00 K(+19.6%) | $1.38 M(-1.6%) |
| Dec 2022 | $1.41 M(+55.1%) | $296.00 K(-17.3%) | $1.41 M(+1.9%) |
| Sep 2022 | - | $358.00 K(-4.5%) | $1.38 M(+12.1%) |
| Jun 2022 | - | $375.00 K(-0.3%) | $1.23 M(+13.3%) |
| Mar 2022 | - | $376.00 K(+39.3%) | $1.09 M(+19.9%) |
| Dec 2021 | $906.00 K(+40.7%) | $270.00 K(+29.2%) | $906.00 K(+8.1%) |
| Sep 2021 | - | $209.00 K(-9.5%) | $838.00 K(+4.8%) |
| Jun 2021 | - | $231.00 K(+17.9%) | $800.00 K(+8.7%) |
| Mar 2021 | - | $196.00 K(-3.0%) | $736.00 K(+14.3%) |
| Dec 2020 | $644.00 K(+50.1%) | $202.00 K(+18.1%) | $644.00 K(+9.5%) |
| Sep 2020 | - | $171.00 K(+2.4%) | $588.00 K(+12.9%) |
| Jun 2020 | - | $167.00 K(+60.6%) | $521.00 K(+14.8%) |
| Mar 2020 | - | $104.00 K(-28.8%) | $454.00 K(+5.8%) |
| Dec 2019 | $429.00 K | $146.00 K(+40.4%) | $429.00 K(+1.2%) |
| Sep 2019 | - | $104.00 K(+4.0%) | $424.00 K(-8.4%) |
| Jun 2019 | - | $100.00 K(+26.6%) | $463.00 K(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $79.00 K(-44.0%) | $515.00 K(-12.1%) |
| Dec 2018 | $586.00 K(-9.7%) | $141.00 K(-1.4%) | $586.00 K(-1.0%) |
| Sep 2018 | - | $143.00 K(-5.9%) | $592.00 K(-4.1%) |
| Jun 2018 | - | $152.00 K(+1.3%) | $617.00 K(-2.7%) |
| Mar 2018 | - | $150.00 K(+2.0%) | $634.00 K(-2.3%) |
| Dec 2017 | $649.00 K(-24.9%) | $147.00 K(-12.5%) | $649.00 K(-2.8%) |
| Sep 2017 | - | $168.00 K(-0.6%) | $668.00 K(+0.1%) |
| Jun 2017 | - | $169.00 K(+2.4%) | $667.00 K(-10.7%) |
| Mar 2017 | - | $165.00 K(-0.6%) | $747.00 K(-13.5%) |
| Dec 2016 | $864.00 K(-16.8%) | $166.00 K(-0.6%) | $864.00 K(-12.0%) |
| Sep 2016 | - | $167.00 K(-32.9%) | $982.00 K(-8.8%) |
| Jun 2016 | - | $249.00 K(-11.7%) | $1.08 M(-3.2%) |
| Mar 2016 | - | $282.00 K(-0.7%) | $1.11 M(+7.2%) |
| Dec 2015 | $1.04 M(+40.7%) | $284.00 K(+8.4%) | $1.04 M(+8.2%) |
| Sep 2015 | - | $262.00 K(-8.1%) | $959.00 K(+9.0%) |
| Jun 2015 | - | $285.00 K(+37.7%) | $880.00 K(+14.3%) |
| Mar 2015 | - | $207.00 K(+1.0%) | $770.00 K(+4.3%) |
| Dec 2014 | $738.00 K(+4.7%) | $205.00 K(+12.0%) | $738.00 K(+38.5%) |
| Sep 2014 | - | $183.00 K(+4.6%) | $533.00 K(+52.3%) |
| Jun 2014 | - | $175.00 K(0.0%) | $350.00 K(+100.0%) |
| Mar 2014 | - | $175.00 K | $175.00 K |
| Dec 2013 | $705.00 K(-10.3%) | - | - |
| Dec 2012 | $786.00 K(-30.6%) | - | - |
| Dec 2011 | $1.13 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual D&A year-on-year change?
- What is Xenon Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
- What is Xenon Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM D&A year-on-year change?
What is Xenon Pharmaceuticals annual depreciation & amortization?
The current annual D&A of XENE is $2.56 M
What is the all time high annual D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual depreciation & amortization is $2.56 M
What is Xenon Pharmaceuticals annual D&A year-on-year change?
Over the past year, XENE annual depreciation & amortization has changed by +$499.00 K (+24.21%)
What is Xenon Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of XENE is $633.00 K
What is the all time high quarterly D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly depreciation & amortization is $1.73 M
What is Xenon Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, XENE quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of XENE is $2.56 M
What is the all time high TTM D&A for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM depreciation & amortization is $2.99 M
What is Xenon Pharmaceuticals TTM D&A year-on-year change?
Over the past year, XENE TTM depreciation & amortization has changed by $0.00 (0.00%)